You might be interested in the continuing HUNT2 research, covering over 52,000 Norwegians. The authors of this 2012 paper suggest that current medical advice has got the cholesterol thing wrong.
Many clinical guidelines for cardiovascular disease (CVD) prevention contain risk estimation charts/calculators. These have shown a tendency to overestimate risk, which indicates that there might be theoretical flaws in the algorithms. Total ...
www.ncbi.nlm.nih.gov
Conclusion:
Our study provides an updated epidemiological indication of possible errors in the CVD risk algorithms of many clinical guidelines. If our findings are generalizable, clinical and public health recommendations regarding the ‘dangers’ of cholesterol should be revised. This is especially true for women, for whom moderately elevated cholesterol (by current standards) may prove to be not only harmless but even beneficial.
Statins will certainly reduce cholesterol. The issue is whether cholesterol needs to be reduced.